Response to 'The end of the dosage of 6 Thioguanine nucleotides? Not so sure…'.

Akbar K. Waljee,a,b Kay Sauder,b Anand Patel,c Sandeep Segar,c Yiwei Zhang,d Ji Zhu,d Ryan W. Stidham,b Ulysses Balis,e Peter D. R. Higginsb aDepartment of Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA bDivision of Gastroenterology, Department of Internal Medicine, University of Michigan, MI, USA cDepartment of Internal Medicine, University of Michigan, MI, USA dDepartment of Statistics, University of Michigan, MI, USA eDepartment of Pathology, University of Michigan, MI, USA

[1]  X. Roblin,et al.  The End of the Dosage of 6-Thioguanine Nucleotides? Not so Sure…. , 2018, Journal of Crohn's & Colitis.

[2]  P. Higgins,et al.  External Validation of a Thiopurine Monitoring Algorithm on the SONIC Clinical Trial Dataset , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  Siddharth Singh,et al.  American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease. , 2017, Gastroenterology.

[4]  P. Higgins,et al.  Machine Learning Algorithms for Objective Remission and Clinical Outcomes with Thiopurines , 2017, Journal of Crohn's & colitis.

[5]  E. Seidman,et al.  Therapeutic drug monitoring in inflammatory bowel disease , 2014, Annals of gastroenterology.

[6]  Christopher F. Martin,et al.  Randomised clinical trial: individualised vs. weight‐based dosing of azathioprine in Crohn's disease , 2014, Alimentary pharmacology & therapeutics.

[7]  F. Casellas,et al.  Thiopurine methyl‐transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine‐treated inflammatory bowel disease patients , 2011, Alimentary pharmacology & therapeutics.

[8]  V. Armstrong,et al.  6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial. , 2007, Clinical chemistry.